Getting Allergen Percentages From a Supplier Fragrance Doc
Reading a supplier's allergen declaration sheet correctly is what tells you whether your fragrance blend crosses a disclosure threshold.
Reading a supplier's allergen declaration sheet correctly is what tells you whether your fragrance blend crosses a disclosure threshold.
A commercial evaluation authorisation lets you market-test a new chemical in Australia before committing to full introduction.
Whether a cosmetic needs a durability date on its label often comes down to shelf life, and it interacts with PAO in ways worth understanding.
How NMPA splits cosmetics into a simple notification path and a stricter registration path, and how to tell which applies to your product.
How one company running multiple cosmetic brands should structure facility registration, product listings, and the responsible person under MoCRA.
A walkthrough of the EU Login and SAAS access steps you need before you can even open a CPNP notification screen.
Reading a titanium dioxide safety data sheet for grade, particle size, and CAS details before you file a mineral sunscreen or makeup product.
How Canada's dealer name and place-of-business rule works for makers, importers, and private label sellers.
How to name goat milk and typical soap additives correctly on an ingredient list, and when the bar stops being a plain soap.
How a UK or EU cosmetics brand layers a Canada CNF onto compliance work they've already done, without redoing everything from zero.
How INCI naming ties back to AICIS chemical identity for cosmetics sold in Australia, and where the two systems diverge.
The CPNP portal fee is zero, but the real cost of an EU cosmetic notification lives in the Responsible Person, CPSR, and testing around it.
Why some Hotlist restricted ingredients require exact cautionary label text, and what happens when a filing omits it.
The document checks and category gating Amazon Handmade applies to beauty listings, and why shipping into Canada adds a CNF filing on top.
Why CBD and other cannabis-derived cosmetic ingredients run into more than one Canadian framework, and how that differs from a typical Hotlist restriction.
What a frame formulation actually is in the CPNP, when it saves you real work, and how to choose the right one without over-disclosing your recipe.
A scenario walkthrough for private-label and marketplace cosmetic sellers figuring out who is the MoCRA responsible person and who must register.
How to handle a fragrance allergen calculation that lands right on Canada's 0.001 or 0.01 percent disclosure line, and why you should not round your way out of it.
Why a plain shave cream files as a cosmetic in Canada, and how one antibacterial or medicated claim can push the same product into drug territory.
Why hydrogen peroxide's Hotlist ceiling changes depending on whether it ends up in a skin, hair, or oral product, and what warnings follow each.
Why rinse-off products get a threshold ten times higher than leave-on ones for fragrance allergen disclosure, and what that means for shampoo and cleanser formulas.
What MoCRA's professional-use labeling statement actually says, and which salon and spa distribution setups genuinely need it.
How EU competent authorities inspect a cosmetic, what they ask for from the Responsible Person, and how a Safety Gate recall gets triggered.
Where radiance and glow language ends and pigment-correction drug claims begin, with concrete wording examples for makers.